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Background: Clinical examination and lymphoscintigraphy are the current standard for investigating lymphatic function.
Magnetic resonance imaging (MRI) facilitates three-dimensional (3D), nonionizing imaging of the lymphatic vasculature,
including functional assessments of lymphatic flow, and may improve diagnosis and treatment planning in disease states
such as lymphedema.
Purpose: To summarize the role of MRI as a noninvasive technique to assess lymphatic drainage and highlight areas in
need of further study.
Study Type: Systematic review.
Population: In October 2019, a systematic literature search (PubMed) was performed to identify articles on magnetic reso-
nance lymphangiography (MRL).
Field Strength/Sequence: No field strength or sequence restrictions.
Assessment: Article quality assessment was conducted using a bespoke protocol, designed with heavy reliance on the
National Institutes of Health quality assessment tool for case series studies and Downs and Blacks quality checklist for
health care intervention studies.
Statistical Tests: The results of the original research articles are summarized.
Results: From 612 identified articles, 43 articles were included and their protocols and results summarized. Field strength
was 1.5 or 3.0 T in all studies, with 25/43 (58%) employing 3.0 T imaging. Most commonly, imaging of the peripheries,
upper and lower limbs including the pelvis (32/43, 74%), and the trunk (10/43, 23%) is performed, including two studies
covering both regions. Imaging protocols were heterogenous; however, T2-weighted and contrast-enhanced T1-weighted
images are routinely acquired and demonstrate the lymphatic vasculature. Edema, vessel, quantity and morphology, and
contrast uptake characteristics are commonly reported indicators of lymphatic dysfunction.
Data Conclusion: MRL is uniquely placed to yield large field of view, qualitative and quantitative, 3D imaging of the lym-
phatic vasculature. Despite study heterogeneity, consensus is emerging regarding MRL protocol design. MRL has the
potential to dramatically improve understanding of the lymphatics and detect disease, but further optimization, and
research into the influence of study protocol differences, is required before this is fully realized.
Level of Evidence: 2
Technical Efficacy: Stage 2
J. MAGN. RESON. IMAGING 2021.
Introduction
Lymphedema is a condition characterized by the accumulation
of lymph in the tissue leading to chronic swelling.1 As of
2012, lymphedema was estimated to affect as many as 250 mil-
lion people worldwide, the majority of which are caused by
filariasis in developing nations.2 Lymphedema is also prevalent
in developed nations; as many as one in 1000 Americans may
be affected.1 Despite the prevalence, methods of investigating
human lymphedema are few and comparatively small numbers
of medical professionals specialize in disorders of the lymphatic
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system.3 In vivo imaging of the lymphatics may improve
understanding of the underlying causes and mechanisms of
lymphatic disorders, and aid diagnosis.
Lymphoscintigraphy (LS) is currently considered the
clinical standard for lymphatic imaging, with direct X-ray
lymphography typically phased out given its invasive nature.4
While the radiolabeled bolus used in LS is selectively taken
up by the lymphatics, making it highly specific, LS is limited
by poor spatial and temporal resolution, and is typically lim-
ited to generating two-dimensional (2D) projections of the
main lymphatic pathways (see Fig. 1).5,6 There is also a small
radiation dose associated with LS.
Indocyanine green (ICG) lymphography, a fluorescence
imaging technique (see Fig. 2), overcomes the poor spatial
and temporal resolution of LS and is also highly specific to
the lymphatics given ICG’s protein binding properties. ICG
lymphography is limited by an inability to produce three-
dimensional (3D) images and to imaging only superficial lym-
phatic vessels (LVs).7
Magnetic resonance lymphangiography (MRL) is uniquely
positioned to yield nonionizing, high spatial resolution 3D imag-
ing of the lymphatic vasculature from head to foot, and appears
capable of yielding functional characteristics of lymphatic trans-
port.8,9 MRL has garnered increased interest and many small
cohort studies, in participants with confirmed or suspected lym-
phatic abnormalities, have been published.10–15 Studies investigat-
ing the technical aspects of MRL, and the complexities associated
with imaging specific anatomical sites, are less common.
Optimized MRL protocols, with specific study aims, are
key to unlocking MRL’s potential for investigating lymphatic
function. The aim of this review is to focus on the technical
aspects of MRL, discussing potential pitfalls, innovative
approaches, and areas in need of further research, while also




A search of MRL literature was performed using PubMed
with search terms: ([lymphography OR lymphangiography]
OR Lymphatic angiography OR Lymph angiography) AND
FIGURE 1: Lymphoscintigram (a) and magnetic resonance
lymphangiogram (b) acquired in the lower limbs of a participant
with lymphedema of the right lower limb. MRI was acquired
after contrast injection in the affected limb with a contrast-
enhanced 3D T1-weighted gradient echo sequence with TR/
TE = 4.13/1.47 msec, flip angle = 25, reconstructed voxel
size = 0.80 × 0.80 × 0.80 mm. Both modalities show regions of
dermal reflex (open arrows). The lymphoscintigram also shows a
normal appearing main lymphatic pathway leading to the
inguinal lymph nodes in the unaffected (left) limb (filled arrow).
Reproduced from Weiss et al.,5 with permission.
FIGURE 2: Lower limb indocyanine green (ICG) fluorescence
image, showing the lateral aspect of the shin, in a participant with
unilateral lower limb lymphedema acquired by St George’s
Lymphovascular Research Group. ICG binds to proteins such as
albumin making imaging specific to the lymphatics. This image
was produced via laser excitation of the ICG after intradermal
injection between the digital webspaces, and subsequent
detection of the fluorescence by a CCD detector. High spatial
resolution allows identification of individual superficial lymphatic
vessel (solid arrow); however, emissions from deeper lying
structures are quickly attenuated. In the unaffected individual,
fairly linear vessel pathways flowing distally to proximally, and
following known anatomical pathways, should be observed. In an
affected state, an abnormal drainage pattern is evident such as no
flow, medial to lateral (or vice versa) flow, and dermal rerouting
(dashed arrow). Image “Lower limb ICG in unilateral lymphedema”
shared by St George’s Lymphovascular Research Group under the
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(MRI OR MRL OR MR-L OR Magnetic resonance*).
English language publications, published between October
7, 1999 and October 7, 2019, were included. Studies publi-
shed prior to 1999 were not considered. Animal studies were
not initially excluded to avoid removing articles which study
both human and animal subjects. Manual literature searching
provided several additional references.
Inclusion Criteria
After inspection for duplicates, vetting following the Preferred
Reporting Items for Systematic Reviews and Meta-Analyses
guidelines was performed.16 A single reviewer
(MM) performed an initial three-stage filtering:
1. Abstracts not referencing lymphatic magnetic resonance
imaging (MRI) or only lymph nodes (LNs) were excluded.
Single case reports, letters or replies, and book chapters
were also removed.
2. Full texts were retrieved and vetted with the criteria above
and the requirement that scanning parameters were
present.
3. Studies involving only animals were excluded, retaining
those with both human and animal subjects.
Quality Appraisal
Two reviewers (MM and MvZ), with 6 and 3 years of MRI
experience, respectively, assessed the quality of the remaining stud-
ies using a purpose designed tool produced with heavy reliance on
the National Institutes of Health quality assessment tool for case
series studies and Downs and Blacks quality checklist for health
care intervention studies.17,18 Consisting of nine questions, it
assessed the clarity of the imaging and contrast injection protocols,
potential bias in participant selection, participant compliance, and
technical imaging concerns. Articles in this study are those consid-
ered of high quality, scoring ≥60% of the points available. Where
reviewers disagreed, inclusion was by consensus, or else by a third
reviewer (MB) with over 15 years of MRI experience. The full
quality appraisal protocol can be found in the Supplementary
Material. The article inclusion process is shown in Fig. 3.
Results
Included Articles
A total of 43 articles, of an initial 612, were selected after
screening and quality appraisal. Magnetic field strength was
1.5 T or 3.0 T in all studies, with 25/43 (58%) studies
employing 3.0 T imaging. No human LV studies performed
at 7.0 T were identified within any of the initial 612 articles.
The most commonly imaged anatomical regions were the
peripheries, upper and lower limbs including the pelvis
(32/43, 74%), and the trunk (10/43, 23%). Additionally,
three studies were performed in the head and neck.
For all included studies, imaging and contrast injection
protocols, and summary study findings, have been collated
(Tables 1–4). Imaging details for noncontrast and contrast-
enhanced (CE) studies can be found in Tables 1–2, while
Table 3 outlines contrast injection protocols. These compre-
hensive tables have been compiled to allow direct comparison
of individual studies and show the breadth of applied
methodologies.
Reported MRL protocols vary widely; however, 3D
heavily T2-weighted and CE T1-weighted sequences are com-
monly employed. Maximum intensity projection (MIP)
reformatting of the entire imaged volume, including MIP
images from each phase of dynamic CE-MRL studies, is regu-
larly employed to aid visualization of the enhancing
structures.
NONCONTRAST T2-WEIGHTED IMAGING. A fluid-
sensitive heavily T2-weighted fast/turbo spin echo (FSE/TSE)
sequence (note that the generic term “rapid acquisition with
relaxation enhancement,” or RARE, is also in use), similar to
those used to image the biliary system, is performed in the
vast majority of studies acquiring non-CE images (22/29, see
Table 1). Ex vivo, the T2 time of lymph has been measured
at 610 msec (3.0 T) and hence can be expected to retain rea-
sonable signal in heavily T2-weighted images.
9 An example
T2-weighted MRL image of the lower limbs clearly displaying
LVs can be seen in Fig. 4. Typical timing parameters for
these sequences are of the order repetition/echo time (TR/
TE) = 3000–4000/500–700 msec at both 1.5 T and 3.0 T
with voxel sizes typically >1 mm3 (Table 1). Image accelera-
tion techniques such as partial Fourier acquisitions and use of
parallel imaging were reported in eight studies employing T2-
weighted spin echo sequences (11 studies in total, as shown
in Table 1); however, the effect on acquisition time is unclear
as this was rarely reported. In those which do, 2–11 minute
acquisitions have been reported (see Table 1).
Individual studies employed arterial spin labeling (ASL),
time of flight (TOF) and steady-state free precession tech-
niques to achieve specific goals such as detecting lymphatic
flow in the meningeal lymphatics, estimating the speed of
lymphatic flow and to acquire venographic images.
CE T1-WEIGHTED IMAGING. Paramagnetic gadolinium-
based contrast agents (GBCAs) have been shown capable of
reducing the long native T1 time of lymph sufficiently to pro-
duce high signal intensity T1-weighted images, as demon-
strated for the thoracic duct (TD) in Fig. 5. Dynamic
imaging, demonstrating temporal changes in contrast distri-
bution, is common, with volumes acquired in
30–180 seconds (Table 2).
Short TR and TE 3D spoiled gradient echo (SPGR)
sequences, with typical scanning parameters of TR/TE = 3–
6 msec/1–2 msec and flip angle (FA) =12–30 regardless of
field strength, were most often employed (24/33). Image
acceleration techniques were rarely reported in these studies;
3
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only one study employing SPGR indicated the use of partial
Fourier, while four studies employed parallel imaging. Signal-
to-noise ratio (SNR) in CE T1-weighted images appears
superior to T2-weighted ones: Crescenzi et al. reported SNR
of approximately 10 in the arm and torso LVs using
T2-weighted TSE at 3.0 T,
25 while Mazzei et al. measured
FIGURE 3: Study selection flow chart. PubMed revealed 609 English language sources after a search for lymphatic vessel magnetic
resonance imaging. After vetting and quality assessment, a total of 43 articles were included in this review, the majority of which
report imaging in the limbs and/or pelvis (collectively labeled the “peripheries”). Note that some studies cover both the torso and
the limbs and so are counted twice. One study, performing peripheral MRL and a single case of torso MRL, was included for review
with the single torso case excluded.
4























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Mills et al.: Systematic Review of MRL
peak SNR in leg LVs of >250 with a CE SPGR sequence at
1.5 T.27 Spatial resolution is also typically superior in T1-
weighted images compared to T2-weighted with voxel sizes
1 mm3 reported regularly.
Dixon-based imaging is performed by some authors as a
proactive fat suppression technique and by others employing
the use of a contrast agent to suppress signal from blood
vessels.
CONTRAST INJECTION PROTOCOL. Six different GBCAs
were employed within the included studies (Table 3). These
agents were often combined with local anesthetic for pain
relief, and in one case a small volume of a vasoconstrictor to
test if this reduced undesirable venous enhancement44; a
common issue for peripheral CE-MRL. Gadopentetate dim-
eglumine and gadobenate dimeglumine were the most often
employed GBCAs (12 and 10 instances, respectively), while
the use of gadoterate meglumine was only described in a sin-
gle study.
When performing CE studies in the peripheries,
between 2 and 5 injections of 1 mL GBCA solution were
delivered into the digital web spaces, either intradermally or
subcutaneously, with small gauge (eg, 24 G) needles. In the
trunk (i.e. from pelvis to neck) larger volume injections (eg,
2–8 mL) administered via the inguinal LNs were more
common.
Massage of the contrast injection site was performed in
approximately half of peripheral MRL (pMRL) studies, often
citing research demonstrating improved contrast uptake into
the lymphatics of rabbits.58 Massage durations varied between
0.5 and 5 minutes.
Clinical Value
Visualization of LVs is common in T1-weighted studies, even
in healthy limbs,34,41,42 as is recording their abundance
and size.
T2-weighted studies appear particularly sensitive to the
detection of areas of fluid accumulation and the presence of
the so called honeycombing pattern (Fig. 6), thought to be a
marker of tissue fibrosis.60 LVs are also visualized in
T2-weighted images; however, this may be improved by spe-
cific image optimization: Crescenzi et al. acquired images at
3.0 T with a range of echo times and were only able to clearly
visualize LVs at TE = 121 msec, an echo time much shorter
than is typical.61
LVs are often reported as being larger in participants
with lymphedema, and regions of dermal backflow (rerouting
of lymphatic fluid to the dermal lymphatics) are regularly
observed (Fig. 7).
FIGURE 4: Maximum intensity projected T2-weighted
noncontrast MRL image of a participant with unilateral
lymphedema of the left leg. TR/TE = 4000/884 msec, flip
angle = 90, voxel size = 0.8 × 1.4 mm, acquired with a driven
equilibrium pulse. Many tortuous vessel-like structures are seen
in the left leg (solid arrows), with signal intense areas of fluid
accumulation seen by the left ankle (dashed arrows). High signal
structures are also observed at the right ankle (diamond headed
arrow). The high signal in the vessel-like structures seen in the
left limb may be due to vessel dilation and/or fluid stasis, both
of which can occur as a result of pathology. Reproduced from
Arrivé et al.,28 with permission.
FIGURE 5: Thoracic duct MRL of a participant with bilateral upper
and lower limb lymphedema acquired with a contrast-enhanced
T1-weighted SPGR by St George’s Lymphovascular Research
Group. TR/TE = 5.2 / 1.8 msec, flip angle = 30, reconstructed
voxel size = 0.75 × 0.75 × 1.50 mm. This MIP clearly displays
contrast draining through a single smooth channeled thoracic
duct (solid arrow), which appears to bifurcate and drain bilaterally
(dashed arrows) . Image “Thoracic duct MRL in lymphedema”
shared by St George’s Lymphovascular Research Group under the
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Dynamic CE studies regularly document the temporal
nature of lymphatic enhancement (eg, time to peak signal, or
signal vs. time curves), with two authors reporting lymph
flow speed estimates: Liu et al. estimated speeds between 0.3
and 1.48 cm/minute in the legs of primary lymphedema par-
ticipants, while Borri et al. recorded a speed of 9.7 cm/minute
in the arm of a single participant with breast cancer related
lymphedema (BCRL).8,35 Rane et al. measured lymph speed
in the arms of healthy controls and BCRL patients using
pulsed ASL. Altered lymph dynamics were demonstrated,
with a reduction in lymph speed observed in the affected
vs. unaffected arms of patients; mean = 0.61  0.22 cm/
minute vs. 0.48  0.15 cm/minute.9
Kuo et al. were able to demonstrate lymph flow in the
head, adjacent to the superior sagittal sinus (SSS), via TOF
imaging.19 Employing spatially selective saturation bands, the
direction of flow within the meningeal lymphatics was also
demonstrated as being counter to the blood flow of the SSS.
Table 4 summarizes common findings in the included
studies.
Comparisons to Lymphoscintigraphy
Several studies include comparisons of the performance of
MRL with LS and comment on the concordance between
imaging findings across modalities. In all studies, improved
LV visualization with MRL in the limbs was reported.5,6,34,43
Improved detection of inguinal LNs was reported by Liu
et al. when comparing CE-MRL to LS (16/17 vs. 9/17
patient images displaying inguinal nodes for CE-MRL
vs. LS), while Notohamiprodjo et al. report the converse.6,43
In a study considering LS as the gold standard technique,
Weiss et al. reported sensitivity and specificity values of 68%
and 91% for detection of focal lymphatic lesions
(eg, lymphocele or dermal backflow) by CE-MRL compared
to LS.5 Figure 1 shows example LS and MRL images from
the same participant.
Site Specific Considerations
PERIPHERAL MRL. MRL has been successfully performed in
the arms and legs of participants diagnosed with lymphedema
(Figs. 1, 4, 6–7) and healthy participants (Fig. 8).
CE-pMRL is susceptible to the contaminant enhance-
ment of venous structures alongside the lymphatics, however.
Despite some authors reporting no difficulty distinguishing
enhancing veins from lymphatics based on their appearance,
others indicate that venous signal complicates anatomical
labeling of enhancing structures.27,62,63 Consequently, multi-
ple attempts have been made to proactively reduce the influ-
ence of venous enhancement, including: waiting for the
venous enhancement to subside35,53; collecting a venogram to
identify veins62,64; injection of ultrasmall superparamagnetic
FIGURE 6: T2-weighted TSE image of a participant with lower
limb lymphedema in the left limb demonstrating a clear
honeycomb pattern of the subcutaneous tissue (arrow).
Acquired with TR/TE = 2870/797 msec, voxel
size = 1.1 × 1.0 × 1.0 mm. Reproduced from Cellina et al.,59
with permission.
FIGURE 7: Contrast-enhanced image of the left arm of an
individual with lymphedema showing a region of dermal
backflow, the rerouting of lymph to the dermal lymphatics.
Acquired with a fat suppressed SPGR, TR/TE = 3.5/1.3 msec, flip
angle = 14.9, voxel size = 1.0 × 1.4 × 1.2 mm. Reproduced
from Bae et al.,34 with permission.
17
Mills et al.: Systematic Review of MRL
iron oxide (USPIO) for venous suppression40,57; or reducing
the injected GBCA concentration8 (additionally reducing T2-
related signal loss at the injection site, observed as early as
200650).
Given the short T1 time of fat, the majority of T1-weighted
CE-pMRL studies are performed fat suppressed (Table 2).
MRL OF THE TRUNK. MRL imaging of peripheral lym-
phatics has been an active area of research at least since the
early 1990s (see, eg, Case et al.,65); however, imaging the
lymphatics of the trunk appears not to have been explored
until toward the end of that decade.66 Much of the research
has focused on imaging the pathway from the two lumbar
lymphatic trunks through to the termination of the
TD. Figure 3 shows an example of normal appearing TD
anatomy, while Fig. 9 demonstrated a narrowed TD and leak-
age in a patient diagnosed with chylothorax.
The effect of cardiac and respiratory motion is addressed
by many studies imaging the LVs in the trunk. Reducing respi-
ratory motion by acquiring data while participants hold their
breath was performed in several T1-weighted sequences; how-
ever, for lengthy T2-weighted sequences respiratory gated and
cardiac triggered sequences are often preferred (Tables 1–2).
CE studies in the trunk are often acquired after contrast
injection into the inguinal LNs, with needle positioning
requiring ultrasound or X-ray guidance.22,47 Fat suppression
techniques were applied in two of four CE studies of the
trunk, but only one T2-weighted.
MRL OF THE HEAD. Only three studies imaging the head were
included in this review; however, they demonstrate the ability to
detect lymphatic structures in the face, neck, and cranial menin-
ges.19,44,45 Two studies perform CE-T1 imaging while non-
contrast TOF imaging was performed by Kuo et al.19 Figure 10
shows an example TOF image in the head. Similar to pMRL,
Loo et al. reported both enhancement of venous structures, and
signal loss at the injection site where GBCA concentration is
largest.44
MRI studies have begun to investigate the existence and
function of a recently hypothesized fluid system in the brain:
the glymphatic system.67,68 As the name suggests, the
glymphatic system (derived from the terms glial and lym-
phatic) is considered to clear waste from within the brain, as
the lymphatic system does throughout the rest of the body,
FIGURE 8: Lower limb MRL of a healthy participant imaged with a
fat suppressed contrast-enhanced T1 weighted SPGR by St
George’s Lymphovascular Research Group. TR/TE = 3.6 / 1.6 msec,
flip angle = 12, reconstructed voxel size = 0.75 × 0.75 × 0.75 mm.
This MIP demonstrates thin, discontinuous appearing, lymphatic
vessels (solid arrow), as well as larger venous structures (dashed
arrow). Image “Lower limb MRL in healthy participant” shared by St




FIGURE 9: Lymphatic leakage (solid arrow) and thoracic duct
narrowing (dashed arrow) identified 12 minutes into imaging of
a patient with recurrent chylothorax. Acquired with a fat
suppressed SPGR, TR/TE = 4.0/1.9 msec, flip angle = 10, voxel
size = 1.0 × 1.4 × 1.2 mm. Reproduced from Krishnamurthy
et al.,47 with permission.
18
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via the cerebrospinal fluid (CSF). Within the glymphatic
model, CSF flow is not within an independent vascular sys-
tem but instead occurs in the perivascular space (unique to
neural vasculature) surrounding neural vessels, and is driven
by pressure induced from arterial pulsation.67,68 The CSF
then passes through the brain parenchyma, picking up pro-
teins during this passage, before reaching the perivascular
space around the veins and so clearing waste products from
the brain. Dysfunction of this drainage pathway has been
hypothesized to be linked to neurodegenerative diseases such as
Alzheimer’s and Parkinson’s.69 The discovery that drainage of
waste from the brain occurs not only via perivascular space sur-
rounding veins, but also through a meningeal lymphatic system
to the cervical LNs, demonstrates the connection between
these systems.70 Given the connection to the glymphatic sys-
tem and hence potential involvement in neurodegenerative dis-
ease processes, and the demonstration of MRI to investigate
this system in humans, the number of studies reporting menin-
geal lymphatic MRI is only likely to increase.19,71
Discussion
This review provides evidence that MRI of LVs is viable
across the entire body and is capable of demonstrating not
only morphological changes with disease, but also altered flow
dynamics. There remain no standardized protocols for MRL;
however, T1-weighted SPGR post intradermal/subcutaneous
injection of standard GBCA, and noncontrast T2-weighted
sequences may be considered standard approaches.
In an attempt to assist readers considering MRL, the
remainder of this section is dedicated to the discussion of key
technical considerations of MRL protocols and potential ave-
nues of research.
Spatial and Temporal Resolution
The small size of LVs demands high spatial resolutions for visu-
alization, which limits temporal resolution without
advancements in MR hardware (field strength, coil sensitivity,
etc.) and k-space sampling techniques. Clinicians and
researchers should therefore consider which of these parameters
is most important when planning MRL studies.
SPATIAL RESOLUTION AND LV VISUALIZATION. Lymph
vessels are typically sub-millimeter in diameter, with only the
larger trunks and ducts reaching the millimeter scale.72 Com-
pared to 2D, 3D MR acquisitions facilitate thinner slices with
less severe partial volume artifacts (also improving SNR for
the same effective slice thickness), but increase acquisition
times. Gibbs ringing artifacts, series of lines in the image at
abrupt signal boundaries such as bright CE LVs and low sig-
nal background tissue, may be seen propagating in the slice
encoded direction in 3D acquisitions. This is often not
observed unless multi-planer reformatting is performed, how-
ever.73 Regardless of these ringing artifacts, 3D acquisitions
are preferable in studies aiming to visualize individual LVs,
especially in healthy volunteers, or when estimating LV size.
T2-weighted images with relatively low resolutions
(2–3 mm isotropic) appear adequate to identify
lymphedematous regions, so improvements of spatial resolu-
tion may not be necessary for these already lengthy sequences.
If higher resolutions are desired, performing FSE/TSE
sequences including a driven equilibrium (DE) pulse may be
preferred. In DE sequences, a 90 radiofrequency (RF) pulse
at the end of the sequence returns transverse magnetization to
the longitudinal plane, recovering transverse magnetization
faster than normal T1 relaxation alone. This may therefore
accelerate imaging when coupled with reductions in TR, and
so be used to offset the increased acquisition time required
when increasing image resolution.74 Arrivé et al.28 and Jeon
et al.56 employed DE when imaging the limbs of participants
diagnosed with lymphedema.
LYMPHATIC CONTRACTIONS AND LYMPH TRANSPORT.
Lymphatic contractile frequencies have been estimated at
1.39–6.78 contractions/minute in the TD and 5 contrac-
tions/minute at rest in superficial leg lymphatic collector ves-
sels.75,76 These pulsation frequencies are beyond even the
most rapid imaging uncovered in the review. Whether it is
possible using MRL to measure transient signal changes
related to lymph transport, a proxy for lymph pulsation fre-
quency, is yet to be explored, but would require high spatial
and temporal resolutions.
The SNR required would also likely need to be
improved, especially when imaging at higher resolution
(which lowers SNR), in order to detect the signal changes
associated with lymphatic propulsion. Imaging at field
strengths >3.0 T, and the application of advanced acquisition
techniques such as compressed sensing,77 would prove benefi-
cial to enable the required spatial resolution, SNR, and accel-
erated data acquisition.
FIGURE 10: Time of flight (TOF) image in the head of a healthy
volunteer showing signal in the meningeal lymphatics (arrow)
and low signal in the superior sagittal sinus, SSS (arrow head).
Image produced with TR/TE = 30/4.49 msec, flip angle = 10,
voxel size = 0.31 × 0.31 × 1.5 mm, and subtracting images
acquired with saturation bands anterior and posterior to the SSS
from those acquired with a saturation band only anterior to the
SSS. Reproduced from Kuo et al.,19 with permission.
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Physiologically relevant flow measurements have been
acquired from MRI datasets, however. Measurements of bulk
bolus speed (see Table 4), estimated in three studies using
either CE or ASL techniques,8,9,35 demonstrate the potential
of MRI to monitor lymph flow and may prove beneficial for
characterizing lymphatic physiology and diagnosing lymphatic
disorders.
MOTION ARTIFACTS. Heavily T2-weighted TSE/FSE
images remain susceptible to motion artifacts given the long
TE and TR required. Imaging lymphatics within the torso
has focused on the TD, an area susceptible to the effects of
both cardiac and respiratory motion. Proactive steps can be
taken to mitigate this issue, including breath-held acquisi-
tions, however Krishnamurthy et al. found it necessary to
intubate and sedate their participants as age or existing mor-
bidities prevented adequate breath-holds.47 Respiratory gating
and cardiac triggering have been successfully employed in
some of the studies reviewed here, but can elevate total imag-
ing time.20–23,26,46,47 Accelerating imaging, via k-space reduc-
tion techniques or use of DE for example, may also reduce
the likelihood and magnitude of bulk motion artifacts; how-
ever, signal loss due to spin dephasing across the lengthy echo
train of TSE/FSE will persist.
Lymph Signal and Background Signal Suppression
MRL image contrast and signal must be sufficient to both
identify LVs and distinguish them from other body tissues.
Although the SNR in T2-weighted images appears much
lower compared to CE-T1 studies, lymph vessels have been
visualized in both.
Image optimization is a nontrivial process and in gen-
eral MR sequence timing parameters vary as a function of
field strength (B0): both T1 and T2 values of tissues are B0
dependant, typically increasing and decreasing, respectively,
with increases in B0. It is interesting to note the similarity in
sequence parameters for both CE-T1 and noncontrast T2
studies regardless of field strength. This may have arisen as a
result of empirically determined optimal sequence parameters;
however, this is not commented on within the literature.
There is markedly little discussion of optimization of TR/TE
within the articles included in this study: adequate image
quality with the same protocol despite changes in field
strength, and a lack of reported lymph vessel T1 and T2 times
required for robust prospective protocol optimization, may
explain the lack of studies documenting image
optimization.61,78
Flip angle optimization for dynamic CE studies is also
nontrivial and requires clear goals; flip angle choice may be
different if image contrast or dynamic range are to be opti-
mized for example. Higher flip angles maximize T1
weighting, but with an increased potential for generating
higher residual fat signals.79 Flip angles in the range 10–30
have been reported in CE studies, with none detailing in-
depth flip angle optimization.
When imaging in fatty regions, fat suppression tech-
niques can improve contrast-to-noise ratio and lymph conspi-
cuity, and techniques insensitive to inhomogeneities in the
RF field (also referred to as B1 field inhomogeneities) such as
Dixon or spectral attenuated inversion recovery are often
employed. Dixon methods resilient to B0 inhomogeneities
have been developed and so may be considered preferable for
fat suppression. Acquiring the multiple images required for
Dixon studies can increase scan times substantially; however,
multi-echo Dixon acquisitions reduce this time penalty.73,80
Pieper and Schild performed 3D multi-echo Dixon imaging
in participants at 1.5 T. With a resolution of
1.0 × 1.2 × 2.5 mm, they imaged the entire torso with three
image stacks requiring 10 seconds each.48 Further studies
investigating the use of Dixon-based methods across the
entire anatomy are required; however, when robust fat sup-
pression is needed Dixon imaging should be considered.
Although no 7.0 T studies of the LVs were uncovered
in this review, the feasibility of in vivo human LN imaging at
7.0 T has been demonstrated.81–83 Freitag et al., performing
T2-weighted TSE at 7.0 T, highlighted the presence of lymph
vessels connected to LN in their high resolution
(0.2 × 0.2 × 2 mm) images, emphasizing the utility of ultra-
high field strength imaging to generate high-resolution images
with sufficient signal to depict both lymphatic nodes and ves-
sels.83 Imaging at 7.0 T may also enhance visualization of
LVs in healthy limbs which remains difficult at 3.0 T.41,84
DIFFERENTIATING LYMPHATIC AND VENOUS
STRUCTURES. Differentiating venous and lymphatic struc-
tures appears a systemic issue among CE studies. Using vessel
morphology or signal enhancement as potential discriminators
between LV and veins is commonly reported; however, many
authors raise concerns that this approach is insufficient and
may decrease the specificity of MRL.27,62,63
Acquiring separate venographic images, with or without
contrast, may improve visual conspicuity of veins or be used
as subtraction masks for MRL data. Image registration may
be necessary to reduce potentially confounding subtraction
artifacts, however.8,64 Noncontrast venograms were produced
using balanced steady-state free precession (bSSFP) by Mazzei
et al.27 The large T2/T1 ratio of lymph raises the possibility
of the presence of LVs in these venograms, however, as
bSSFP image contrast is T2/T1 weighted.
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The administration of separate USPIO agents in the
bloodstream can suppress venous signal by drastically reduc-
ing T2 times, allowing a selective lymphographic image to be
generated.40,57 At the time of writing, the agent used in these
studies is not licensed for use as an MR contrast agent by the
U.S. Food and Drug Administration or the European Medi-
cines Agency. It should be noted that administration of
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GBCA via skin injection is also considered “off-label”; how-
ever, the safety of GBCA delivered by intravenous injection is
well established. The risks of GBCA administration (allergy,
Gadolinium retention in body tissues, and development of a
rare but serious condition in those with renal function:
nephrogenic systemic fibrosis) should always be carefully con-
sidered prior to injection regardless of route of administration
(intravenous or intradermal). Macrocyclic agents such as
gadobutrol, gadoteridol, and gadoterate meglumine, should
be preferred given their superior safety profiles.86
Protocols employing contrast agents to act specifically
on venous blood introduce additional safety concerns associ-
ated with multiple contrast injections. Large reductions in
contrast agent dose, as employed by Borri et al., have the
effect of both reducing the potential hazards associated with
GBCA delivery and the intensity of venous signal. This, how-
ever, has only been demonstrated in a small pilot cohort of
subjects.8 Alternatively, waiting until the venous signal has
decreased, but lymphatic enhancement remains, has been
suggested to be a simple and effective solution.35 Observation
of temporal behavior of lymphatic transport within this wait
period may be lost; however, estimations of bulk bolus speed
should still be possible.
Contrast Agent Delivery
Six GBCA agents, half of which (gadopentetate dimeglumine,
gadodiamide, and gadobenate dimeglumine) have had their
use restricted within the European Union,86 were used within
the CE studies. Only one publication investigated the use of
different GBCAs (gadoteridol and gadopentetate dim-
eglumine), concluding that enhancement was equivalent.44
This study was conducted in the head and so caution is
advised when drawing on these finding when imaging the
limbs and trunk. Other articles comment on parameters of
GBCAs which may make them optimal for LV studies, such
as higher molecular concentration or stronger protein bind-
ing.10,62,87 A large body of research exists regarding contrast
agent use in LN imaging (see, eg, “MR contrast agents in
lymph node imaging”87), much of which will be relevant to
LV imaging; however, specific studies investigating the use of
different contrast agents for LV imaging are still required.
INJECTED SOLUTION AND CONTRAST MOBILIZATION.
GBCA is most commonly administered undiluted in CE
studies; however, as described previously, Borri et al. propose
injections heavily diluted with saline such that each milliliter
of injected solution contained 0.02 mL of contract agent,
0.1 mL of anesthetic and 0.88 mL saline.8 Krishnamurthy
et al. also diluted their GBCA with saline when performing
intra-nodal injections, using a 1:1 dilution in older patients
and a 1:2 GBCA to saline dilution in younger patients. This
was performed in order to reduce T2 dephasing effects of the
GBCA.47 Loo et al. investigated the effect of delivering
contrast undiluted vs. diluted and different injection volumes,
finding that dilution of GBCA with an equal volume of ster-
ile water, and smaller injections of 0.3–0.5 mL per injection,
provided optimal lymphatic enhancement in the head.44
Massage proximal to the contrast injection site is com-
mon after intradermal/subcutaneous contrast injection, but
there is no clear consensus as to how, or if, to add an inter-
vention to improve contrast mobilization into the lymphatics.
Loo et al. demonstrated that repeated massage extended the
time over which LV enhancement was sustained and pro-
duced additional signal peaks,44 perhaps due to increased
interstitial pressure from the massage driving contrast into the
lymphatics.88,89 Pieper and Schild requested that participants
move their limbs after contrast injection, presumably in an
attempt to increase contrast uptake, a method employed regu-
larly for ICG and LS.48 The extent to which this changed
contrast uptake was not explored, however.
While clear that standard GBCAs can be used for LV
imaging, variable number of injection sites, injected volume,
and GBCA formulation have been employed, and more
research is required before an optimal injection protocol can
be recommended. A systematic exploration of the effect of
different injection and intervention (eg, massage) protocols
on contrast uptake, study repeatability, and to what extent
subtle lymphatic insufficiencies could be masked, is
needed.90–92
Quantitative Analysis
MRL has been shown to visualize structural abnormalities of
the lymphatic system, with additional quantitative analyses
differentiating healthy and abnormal groups. Common mea-
surements include counting visible LVs, estimating vessel
diameter, and recording signal enhancement characteristics.
Many studies use the contralateral limb as an internal
control in both qualitative and quantitative studies. The
results of such comparisons should be approached with cau-
tion as abnormal imaging signs within the contralateral limb
have been observed.26,93 Enrollment of a healthy matched
control cohort would reduce the risk of such confounders.
VESSEL SIZE. The thickness of the TD has been estimated
by multiple authors, often enrolling participants with non-
lymphatic specific abnormalities such as liver malignancy and
a Fontan circulation,20,26 with diameters in the region of
1–7 mm observed. Larger peripheral LVs in individuals with
lymphatic disease have also been commonly observed com-
pared to healthy controls.
Regardless of anatomy, absolute measurements of LV
diameter will be prone to error when voxel sizes are similar
to, or greater than, the vessel size. Acquiring higher spatial
resolution images will improve the accuracy with which LV
size can be estimated. For large field of view studies, 1 mm3
voxels may be approaching the maximum feasible resolution
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for current clinical MR systems. Imaging at higher field
strengths and employing acceleration techniques such as com-
pressed sensing and multiband RF imaging to improve image
resolution should be considered if more representative esti-
mates of vessel size are required.
LYMPH FLOW AND CONTRAST DISTRIBUTION. Time to
peak lymphatic enhancement has been estimated in multiple
CE studies. These values will likely depend on measurement
location and injection protocol (eg, contrast agent, dose, mas-
sage, etc.), and are hence difficult to compare directly.
LS has long been used to estimate lymph drainage by
determining tracer uptake in the LNs.94 Although not
explored in any of the articles reviewed here, similar measure-
ments may be possible via MRL with T1 measurements in
the LVs or LNs yielding estimates of local GBCA concentra-
tion. This requires that sufficiently low injected GBCA con-
centrations and high flip angles are employed to ensure a
linear relationship between image signal and 1/T1 is
maintained. Estimates of T1 will be affected by factors such
as fluid flow and diffusion, partial volume, changes in local
proton-density, and field inhomogeneities, and so will require
good experimental design.95,96
Lymph speed has been estimated in the limbs by three
studies employing different MRL methods and analysis
models. With an ASL based approach, measuring signal as a
function of post-labeling delay time, lymph speed in the arm
was estimated from signal in a downstream LN in the arms
of BCRL patients.9 Imaging the leg, Liu et al. recorded
lymph speeds consistent with those achieved with ASL by
measuring LV length on CE images and calculating speed as
enhanced vessel length divided by the acquisition time.35
Borri et al. recorded slightly higher speeds in their single par-
ticipant with BCRL.8 A five-parameter modified logistic
model was employed to fit signal enhancement, with one
parameter representing the GBCA arrival time. It is interest-
ing to note that despite the methodological differences,
reported speeds are similar (0.5–2 cm/minute) for affected
limbs across these studies.
Is MRL Superior to ICG and LS?
LS is currently considered the clinical gold standard for diag-
nostic lymphatic imaging. Given the sparsity of studies com-
paring techniques directly, or high-level evidence such as
meta-analyses, it is difficult to conclude which technique is
superior. However, it is interesting to note that all studies
within this review comparing MRL and LS report improved
LV visualization in the limbs with MRL.5,6,34,43 The superi-
ority of MRL may also become more evident with further
optimization.
It is perhaps more pertinent to comment on the com-
plementary nature between MRL, LS and ICG lymphogra-
phy, and a combination of MRL with either may deliver a
more complete understanding of lymphatic anatomy and
physiology than MRL alone. While ICG yields high spatial
and temporal imaging of superficial lymph vessels, which may
lead to estimations of vessel contraction frequency, MRL
facilitates evaluation of the lymphatic system over large ana-
tomical regions and can image both superficial and deep lym-
phatic structures such as the TD.26,52 LS, while lacking
spatial and temporal resolution, is readily quantifiable to esti-
mate tracer clearance and hence lymphatic transport. Studies
of lymphatic transport by MRI are being performed, both
noncontrast (using an ASL approach) and contrast-enhanced,
but further research is required before MRL studies of lym-
phatic transport can be interpreted with a high degree of con-
fidence, and routinely implemented.
Conclusion
In conjunction with basic biological research and imaging
techniques such as ICG lymphography, LS, and histology,
MRL can become a powerful tool in gaining a more detailed
understanding of the complexities of the lymphatic system.
The potential for MRL research to directly influence clinical
practice in diseases of the lymphatic system was recently dem-
onstrated in an article reporting 92% sensitivity in identifying
lymphedema with MRL alone.93 Studies investigating factors
such as: the influence of administered contrast agent formula-
tion and massage on contrast uptake characteristics; optimal
imaging parameters for T2-weighted depiction of LVs; and
relevance of quantitative image markers such as estimates of
lymph speed and vessel size to lymphatic function, are still
required to truly unlock MRLs diagnostic and prognostic
potential.
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